Published in Endocrinol Metab (Seoul) on November 03, 2016
Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr (2005) 46.32
Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2008) 6.48
Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol (1992) 4.65
Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol (2002) 4.56
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol (2005) 4.20
Oxidative stress in patients affected by primary aldosteronism. J Hypertens (2014) 3.34
Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet (2008) 2.53
Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. A comparison of cineangiographic and radionuclide techniques. Circulation (1979) 2.30
Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism. Hypertension (2013) 2.25
Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int (2003) 2.13
Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009. Endocr J (2011) 1.67
Aldosterone and vascular inflammation. Hypertension (2008) 1.65
The left atrium: a biomarker of chronic diastolic dysfunction and cardiovascular disease risk. J Am Coll Cardiol (2003) 1.58
Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med (2008) 1.53
Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. Hypertension (2013) 1.41
Inflammatory cytokines in heart failure: mediators and markers. Cardiology (2012) 1.23
Matrix metalloproteinase (MMP)-9: a proximal biomarker for cardiac remodeling and a distal biomarker for inflammation. Pharmacol Ther (2013) 1.21
Interactions between cardiac cells enhance cardiomyocyte hypertrophy and increase fibroblast proliferation. J Cell Physiol (2005) 1.19
Tumor necrosis factor-alpha confers resistance to hypoxic injury in the adult mammalian cardiac myocyte. Circulation (1998) 1.16
Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab (2013) 1.15
Aldosterone-induced oxidative stress: a potential mechanism of aldosterone autonomy in primary aldosteronism. J Hypertens (2014) 1.10
Plasma levels of TNF-alpha and IL-6 are inversely related to cytochrome P450-dependent drug metabolism in patients with congestive heart failure. J Card Fail (2002) 1.08
Aldosterone as a modulator of immunity: implications in the organ damage. J Hypertens (2011) 1.05
Interleukin-18 mediates interleukin-1-induced cardiac dysfunction. Am J Physiol Heart Circ Physiol (2014) 1.00
Prognostic value of serum cytokines in patients with congestive heart failure. J Heart Lung Transplant (2000) 0.98
Aldosterone as a cardiovascular risk factor. Trends Endocrinol Metab (2005) 0.94
Role of NADPH oxidase in atherosclerosis. Future Cardiol (2009) 0.92
Increased levels of oxidative stress, subclinical inflammation, and myocardial fibrosis markers in primary aldosteronism patients. J Hypertens (2010) 0.90
Antioxidant N-acetylcysteine protects pancreatic β-cells against aldosterone-induced oxidative stress and apoptosis in female db/db mice and insulin-producing MIN6 cells. Endocrinology (2013) 0.89
Role of interleukin-6 in regulation of immune responses to remodeling after myocardial infarction. Heart Fail Rev (2015) 0.86
Right adrenal venography findings correlated with C-arm CT for selection during C-arm CT-assisted adrenal vein sampling in primary aldosteronism. Cardiovasc Intervent Radiol (2013) 0.86
An update on novel mechanisms of primary aldosteronism. J Endocrinol (2014) 0.86
Aldosterone causes DNA strand breaks and chromosomal damage in renal cells, which are prevented by mineralocorticoid receptor antagonists. Horm Metab Res (2010) 0.82
Association between urine aldosterone and diastolic function in patients with primary aldosteronism and essential hypertension. Clin Biochem (2014) 0.82
Association of matrix metalloproteinases (MMP2, MMP7 and MMP9) genetic variants with left ventricular dysfunction in coronary artery disease patients. Clin Chim Acta (2012) 0.81
Demonstration of blood pressure-independent noninfarct myocardial fibrosis in primary aldosteronism: a cardiac magnetic resonance imaging study. Circ Cardiovasc Imaging (2012) 0.81
From aldosteronism to oxidative stress: the role of excessive intracellular calcium accumulation. Hypertens Res (2010) 0.80
MMP-2 is localized to the mitochondria-associated membrane of the heart. Am J Physiol Heart Circ Physiol (2013) 0.80
Aldosterone-induced oxidative stress: a potential mechanism of aldosterone autonomy in primary aldosteronism. J Hypertens (2014) 0.77
Impact of aldosterone-producing adenoma on cardiac structures in echocardiography. J Echocardiogr (2013) 0.76
A Randomized Controlled Trial of Compression Rates during Cardiopulmonary Resuscitation. J Korean Med Sci (2016) 0.97
Ultrasonographic scoring system score versus liver stiffness measurement in prediction of cirrhosis. Clin Mol Hepatol (2013) 0.87
Longer survival in patients with breast cancer with cyclin d1 over-expression after tumor recurrence: longer, but occupied with disease. J Breast Cancer (2014) 0.79
Detailed pathologic evaluation on endomyocardial biopsy provides long-term prognostic information in patients with acute myocarditis. Cardiovasc Pathol (2014) 0.77
Conventional versus drug-eluting beads chemoembolization for hepatocellular carcinoma: Emphasis on the impact of tumor size. J Gastroenterol Hepatol (2017) 0.77
Negative Impact of Aromatase Inhibitors on Proximal Femoral Bone Mass and Geometry in Postmenopausal Women with Breast Cancer. Calcif Tissue Int (2015) 0.76
Clinical Implications of the Serum Apelin Level on Portal Hypertension and Prognosis of Liver Cirrhosis. Gut Liver (2016) 0.75
Diagnosis and Treatment of Lower Extremity Deep Vein Thrombosis: Korean Practice Guidelines. Vasc Specialist Int (2016) 0.75
Association between Urine Albumin-to-Creatinine Ratio within the Normal Range and Incident Hypertension in Men and Women. Yonsei Med J (2016) 0.75
Cardiovascular and Metabolic Diseases Etiology Research Center (CMERC) Cohort:the study protocol and results of first 3 years'enrollment. Epidemiol Health (2017) 0.75
Lower Jump Power Rather Than Muscle Mass Itself is Associated with Vertebral Fracture in Community-Dwelling Elderly Korean Women. Calcif Tissue Int (2017) 0.75
The Korean Study of Women's Health-Related Issues (K-Stori): Rationale and Study Design. BMC Public Health (2017) 0.75
Localization of Oncogenic Osteomalacia by Systemic Venous Sampling of Fibroblast Growth Factor 23. Yonsei Med J (2017) 0.75
Raloxifene Use After Denosumab Discontinuation Partially Attenuates Bone Loss in the Lumbar Spine in Postmenopausal Osteoporosis. Calcif Tissue Int (2022) 0.75